CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
ASSETS
Property and equipment, net	$ 33,015	$ 33,489
Asset held for sale, net	10,372	10,334
Cash	401	582
Restricted cash	2,808	2,890
Accounts receivable, net of allowances of $469 and $141	4,367	3,362
Prepaid expenses and other	692	633
Notes receivable	369	369
Intangible assets - bed licenses	2,471	2,471
Intangible assets - lease rights, net	60	69
Right-of-use operating lease assets	1,929	2,154
Goodwill	1,585	1,585
Straight-line rent receivable	2,069	2,527
Total assets	60,138	60,465
LIABILITIES AND EQUITY (DEFICIT)
Senior debt, net	34,238	34,829
Debt related to asset held for sale, net	8,012	8,121
Bonds, net	5,695	5,851
Other debt, net	975	919
Accounts payable	7,082	3,695
Accrued expenses	5,976	5,414
Operating lease obligation	2,220	2,472
Other liabilities	1,394	2,082
Total liabilities	65,592	63,384
Commitments and contingencies (Note 12)
Stockholders' equity (deficit):
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 2,253 shares issued and 2,242 shares outstanding at June 30, 2025; and 1,890 shares issued and 1,879 shares outstanding at December 31, 2024	63,952	63,173
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:
Accumulated deficit	(88,434)	(85,120)
Total stockholders' deficit	(5,454)	(2,919)
Total liabilities and stockholders' deficit	60,138	60,465
Series A Preferred Stock
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:
Preferred stock	426	426
Series B Preferred Stock
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:
Preferred stock	$ 18,602	$ 18,602